M1 macrophages are often considered to be a beneficial cell type for tumor immunotherapy, and recent studies have found that M1 macrophage-derived exosomes carrying miR-16-5p can promote T-cell immunity by reducing PD-L1 expression in gastric cancer cells (Li et al., 2020a). This evidence concerns the gene CD274 and gastric cancer.